FIELD: medicine. SUBSTANCE: isoturone is administrated parenterally (dose is 5 mg/kg body mass) for shock treatment. EFFECT: simultaneous correction of metabolic acidosis and normalization of hemodynamics, decreased therapy complications. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT EFFECTING ON ARTERIAL PRESSURE | 1997 |
|
RU2187309C2 |
| INFUSION SOLUTION | 2019 |
|
RU2708389C1 |
| METHOD OF TREATING TRAUMATIC SHOCK OF III SEVERITY DEGREE | 2018 |
|
RU2677333C1 |
| ANTIHYPOTENSION MEDICATION | 2007 |
|
RU2353614C1 |
| ANTIHYPOTONIC AGENT | 2011 |
|
RU2506082C2 |
| METHOD FOR PREDICTING SEVERITY PATTERN OF HEMORRHAGIC SHOCK AFTER ACUTE MASSIVE HEMORRHAGE | 2002 |
|
RU2224456C1 |
| VASOPRESSOR AGENT | 2013 |
|
RU2552529C1 |
| VASOCONSTRICTOR | 2011 |
|
RU2475479C1 |
| METHOD FOR PATHOGENETICALLY JUSTIFIED EVALUATION OF HYPOVOLEMIA FOR PATIENTS WITH II AND III SEVERITY TRAUMATIC SHOCK | 2016 |
|
RU2618200C1 |
| PREPARATION OF HEMODYNAMIC ACTION WITH THE FUNCTION FOR NORMALIZATION OF ACID-BASE BALANCE AND ELECTROLYTE ONE | 2000 |
|
RU2185173C2 |
Authors
Dates
1994-05-15—Published
1989-05-12—Filed